Mandipropamid; Pesticide Tolerances, 10695-10700 [2019-05406]
Download as PDF
Federal Register / Vol. 84, No. 56 / Friday, March 22, 2019 / Rules and Regulations
ENVIRONMENTAL PROTECTION
AGENCY
40 CFR Part 180
[EPA–HQ–OPP–2017–0671; FRL–9987–25]
Mandipropamid; Pesticide Tolerances
Environmental Protection
Agency (EPA).
ACTION: Final rule.
AGENCY:
This regulation establishes
tolerances for residues of
mandipropamid in or on multiple
commodities which are identified and
discussed later in this document.
Interregional Research Project Number 4
(IR–4) requested these tolerances under
the Federal Food, Drug, and Cosmetic
Act (FFDCA).
DATES: This regulation is effective
March 22, 2019. Objections and requests
for hearings must be received on or
before May 21, 2019, and must be filed
in accordance with the instructions
provided in 40 CFR part 178 (see also
Unit I.C. of the SUPPLEMENTARY
INFORMATION).
SUMMARY:
The docket for this action,
identified by docket identification (ID)
number EPA–HQ–OPP–2017–0671, is
available at https://www.regulations.gov
or at the Office of Pesticide Programs
Regulatory Public Docket (OPP Docket)
in the Environmental Protection Agency
Docket Center (EPA/DC), West William
Jefferson Clinton Bldg., Rm. 3334, 1301
Constitution Ave. NW, Washington, DC
20460–0001. The Public Reading Room
is open from 8:30 a.m. to 4:30 p.m.,
Monday through Friday, excluding legal
holidays. The telephone number for the
Public Reading Room is (202) 566–1744,
and the telephone number for the OPP
Docket is (703) 305–5805. Please review
the visitor instructions and additional
information about the docket available
at https://www.epa.gov/dockets.
FOR FURTHER INFORMATION CONTACT:
Michael Goodis, Registration Division
(7505P), Office of Pesticide Programs,
Environmental Protection Agency, 1200
Pennsylvania Ave. NW, Washington, DC
20460–0001; main telephone number:
(703) 305–7090; email address:
RDFRNotices@epa.gov.
SUPPLEMENTARY INFORMATION:
ADDRESSES:
I. General Information
A. Does this action apply to me?
You may be potentially affected by
this action if you are an agricultural
producer, food manufacturer, or
pesticide manufacturer. The following
list of North American Industrial
Classification System (NAICS) codes is
VerDate Sep<11>2014
16:22 Mar 21, 2019
Jkt 247001
not intended to be exhaustive, but rather
provides a guide to help readers
determine whether this document
applies to them. Potentially affected
entities may include:
• Crop production (NAICS code 111).
• Animal production (NAICS code
112).
• Food manufacturing (NAICS code
311).
• Pesticide manufacturing (NAICS
code 32532).
B. How can I get electronic access to
other related information?
You may access a frequently updated
electronic version of EPA’s tolerance
regulations at 40 CFR part 180 through
the Government Printing Office’s e-CFR
site at https://www.ecfr.gov/cgi-bin/textidx?&c=ecfr&tpl=/ecfrbrowse/Title40/
40tab_02.tpl.
C. How can I file an objection or hearing
request?
Under FFDCA section 408(g), 21
U.S.C. 346a, any person may file an
objection to any aspect of this regulation
and may also request a hearing on those
objections. You must file your objection
or request a hearing on this regulation
in accordance with the instructions
provided in 40 CFR part 178. To ensure
proper receipt by EPA, you must
identify docket ID number EPA–HQ–
OPP–2017–0671 in the subject line on
the first page of your submission. All
objections and requests for a hearing
must be in writing, and must be
received by the Hearing Clerk on or
before May 21, 2019. Addresses for mail
and hand delivery of objections and
hearing requests are provided in 40 CFR
178.25(b).
In addition to filing an objection or
hearing request with the Hearing Clerk
as described in 40 CFR part 178, please
submit a copy of the filing (excluding
any Confidential Business Information
(CBI)) for inclusion in the public docket.
Information not marked confidential
pursuant to 40 CFR part 2 may be
disclosed publicly by EPA without prior
notice. Submit the non-CBI copy of your
objection or hearing request, identified
by docket ID number EPA–HQ–OPP–
2017–0671, by one of the following
methods:
• Federal eRulemaking Portal: https://
www.regulations.gov. Follow the online
instructions for submitting comments.
Do not submit electronically any
information you consider to be CBI or
other information whose disclosure is
restricted by statute.
• Mail: OPP Docket, Environmental
Protection Agency Docket Center (EPA/
DC), (28221T), 1200 Pennsylvania Ave.
NW, Washington, DC 20460–0001.
PO 00000
Frm 00031
Fmt 4700
Sfmt 4700
10695
• Hand Delivery: To make special
arrangements for hand delivery or
delivery of boxed information, please
follow the instructions at https://
www.epa.gov/dockets/contacts.html.
Additional instructions on
commenting or visiting the docket,
along with more information about
dockets generally, is available at https://
www.epa.gov/dockets.
II. Summary of Petitioned-For
Tolerance
In the Federal Register of July 24,
2018 (83 FR 34968) (FRL–9980–31),
EPA issued a document pursuant to
FFDCA section 408(d)(3), 21 U.S.C.
346a(d)(3), announcing the filing of a
pesticide petition (PP 7E8629) by IR–4,
IR–4 Project Headquarters, Rutgers, The
State University of NJ, 500 College Road
East, Suite 201W, Princeton, NJ 08540.
The petition requested that 40 CFR part
180 be amended by establishing
tolerances for residues of
mandipropamid, 4-chloro-N-[2-(3methoxy-4-(2propynyloxy)phenyl]ethyl]-a-(2propynyloxy)-benzeneacetamide], in or
on the raw agricultural commodities:
Asparagus bean, edible podded at 0.90
parts per million (ppm); Bean
(Phaseolus spp.), edible podded at 0.90
ppm; Bean (Vigna spp.), edible podded
at 0.90 ppm; Brassica, leafy greens,
subgroup 4–16B at 25 ppm; Catjang
bean, edible podded at 0.90 ppm;
Celtuce at 20 ppm; Chinese longbean,
edible podded at 0.90 ppm; Citrus, dried
pulp at 0.14 ppm; Citrus, oil at 2.2 ppm;
Cowpea, edible podded at 0.90 ppm;
Florence fennel at 20 ppm; French bean,
edible podded at 0.90 ppm; Fruit, citrus,
group 10–10 at 0.5 ppm; Garden bean,
edible podded at 0.90 ppm; Goa bean,
edible podded at 0.90 ppm; Green bean,
edible podded at 0.90 ppm; Guar bean,
edible podded at 0.90 ppm; Jackbean,
edible podded at 0.90 ppm; Kidney
bean, edible podded at 0.90 ppm;
Kohlrabi at 3 ppm; Lablab bean, edible
podded at 0.90 ppm; Leaf petiole
vegetable subgroup 22B at 20 ppm;
Leafy greens subgroup 4–16A at 25
ppm; Moth bean, edible podded at 0.90
ppm; Mung bean, edible podded at 0.90
ppm; Navy bean, edible podded at 0.90
ppm; Rice bean, edible podded at 0.90
ppm; Scarlet runner bean, edible
podded at 0.90 ppm; Snap bean, edible
podded at 0.90 ppm; Sword bean, edible
podded at 0.90 ppm; Urd bean, edible
podded at 0.90 ppm; Vegetable soybean,
edible podded at 0.90 ppm; Vegetable,
Brassica, head and stem, group 5–16 at
E:\FR\FM\22MRR1.SGM
22MRR1
10696
Federal Register / Vol. 84, No. 56 / Friday, March 22, 2019 / Rules and Regulations
3 ppm; Velvet bean, edible podded at
0.90 ppm; Wax bean, edible podded at
0.90 ppm; Winged pea, edible podded at
0.90 ppm; and Yardlong bean, edible
podded at 0.90 ppm.
Additionally, the petition requested to
amend 40 CFR 180.637 by removing the
tolerances for residues of
mandipropamid in or on the raw
agricultural commodities Bean, snap at
0.90 ppm; Brassica, head and stem,
subgroup 5A at 3 ppm; Brassica, leafy
greens, subgroup 5B at 25 ppm; and
Vegetable, leafy except Brassica, group
4 at 20 ppm.
That document referenced a summary
of the petition prepared by Syngenta
Crop Protection, the registrant, which is
available in the docket, https://
www.regulations.gov. There were no
comments received in response to the
notice of filing.
Based upon review of the data
supporting the petition, EPA has
modified the levels at which some
tolerances are being established as well
as some of the commodities in which
tolerances are being established. The
reason for these changes are explained
in Unit IV.C.
III. Aggregate Risk Assessment and
Determination of Safety
Section 408(b)(2)(A)(i) of FFDCA
allows EPA to establish a tolerance (the
legal limit for a pesticide chemical
residue in or on a food) only if EPA
determines that the tolerance is ‘‘safe.’’
Section 408(b)(2)(A)(ii) of FFDCA
defines ‘‘safe’’ to mean that ‘‘there is a
reasonable certainty that no harm will
result from aggregate exposure to the
pesticide chemical residue, including
all anticipated dietary exposures and all
other exposures for which there is
reliable information.’’ This includes
exposure through drinking water and in
residential settings, but does not include
occupational exposure. Section
408(b)(2)(C) of FFDCA requires EPA to
give special consideration to exposure
of infants and children to the pesticide
chemical residue in establishing a
tolerance and to ‘‘ensure that there is a
reasonable certainty that no harm will
result to infants and children from
aggregate exposure to the pesticide
chemical residue . . . .’’
Consistent with FFDCA section
408(b)(2)(D), and the factors specified in
FFDCA section 408(b)(2)(D), EPA has
reviewed the available scientific data
and other relevant information in
support of this action. EPA has
sufficient data to assess the hazards of
and to make a determination on
aggregate exposure for mandipropamid
including exposure resulting from the
tolerances established by this action.
VerDate Sep<11>2014
16:22 Mar 21, 2019
Jkt 247001
EPA’s assessment of exposures and risks
associated with mandipropamid
follows.
A. Toxicological Profile
EPA has evaluated the available
toxicity data and considered its validity,
completeness, and reliability as well as
the relationship of the results of the
studies to human risk. EPA has also
considered available information
concerning the variability of the
sensitivities of major identifiable
subgroups of consumers, including
infants and children.
Subchronic and chronic studies
indicate that the liver and kidney are
the primary target organs for
mandipropamid. Liver effects observed
in subchronic studies with rats, mice
and dogs included periportal
hypertrophy (rats), increased
eosinophilia (rats and mice), increased
plasma albumin, total protein,
cholesterol, and gamma-glutamyl
transferase (rats), increased liver
weights (rats, mice and dogs), increased
liver enzymes (dogs), increased pigment
in hepatocytes and Kupffer cells (dogs),
and centrilobular hepatocyte
vacuolation (dogs). In the chronic dog
study, increases in microscopic pigment
in the liver, and increased liver enzymes
were observed. In the chronic rat and
mouse studies, liver toxicity was not
observed. Nephrotoxicity was observed
in the chronic rat study; however, in the
chronic mouse study, only decreased
body weight and food utilization were
observed. The findings of liver toxicity
and nephrotoxicity are consistent with
the results from metabolism studies, in
which radioactivity levels in liver and
kidney were typically higher than other
tissues. There were no consistent sexrelated differences in target organ
toxicity, although male rats appeared to
be more sensitive to body weight effects.
No evidence of neurotoxicity was
observed in the database, including rat
acute or subchronic neurotoxicity
studies. No systemic or dermal toxicity
was observed in the rat following
dermal exposure for 28 days up to the
limit dose.
No evidence of increased pre- or
postnatal quantitative or qualitative
susceptibility was observed. No fetal or
maternal toxicity was observed in
developmental toxicity studies in the rat
and rabbit. Decreased pup weights were
observed in the rat two-generation
reproduction study in the presence of
decreased parental body weight and
food utilization.
There was no evidence of a treatmentrelated increase in tumor incidence in
the mouse carcinogenicity study or the
rat chronic/carcinogenicity study. There
PO 00000
Frm 00032
Fmt 4700
Sfmt 4700
was no evidence of genotoxicity in
bacterial reverse gene mutation,
mammalian in vitro forward gene
mutation, mammalian in vivo
clastogenicity, or unscheduled DNA
synthesis assays. Therefore,
mandipropamid is classified as ‘‘not
likely to be carcinogenic to humans.’’
Specific information on the studies
received and the nature of the adverse
effects caused by mandipropamid as
well as the no-observed-adverse-effectlevel (NOAEL) and the lowest-observedadverse-effect-level (LOAEL) from the
toxicity studies can be found at https://
www.regulations.gov in the document
titled ‘‘Mandipropamid. Aggregate
Human Health Risk Assessment
Supporting Section 3 Registration of
Proposed New Uses on Citrus Fruits
Group 10–10 and Succulent Beans,
Along with Various Crop Group and
Subgroup Conversions’’ on pages 35–39
in docket ID number EPA–HQ–OPP–
2017–0671.
B. Toxicological Points of Departure/
Levels of Concern
Once a pesticide’s toxicological
profile is determined, EPA identifies
toxicological points of departure (POD)
and levels of concern to use in
evaluating the risk posed by human
exposure to the pesticide. For hazards
that have a threshold below which there
is no appreciable risk, the toxicological
POD is used as the basis for derivation
of reference values for risk assessment.
PODs are developed based on a careful
analysis of the doses in each
toxicological study to determine the
dose at which no adverse effects are
observed (the NOAEL) and the lowest
dose at which adverse effects of concern
are identified (the LOAEL). Uncertainty/
safety factors are used in conjunction
with the POD to calculate a safe
exposure level—generally referred to as
a population-adjusted dose (PAD) or a
reference dose (RfD)—and a safe margin
of exposure (MOE). For non-threshold
risks, the Agency assumes that any
amount of exposure will lead to some
degree of risk. Thus, the Agency
estimates risk in terms of the probability
of an occurrence of the adverse effect
expected in a lifetime. For more
information on the general principles
EPA uses in risk characterization and a
complete description of the risk
assessment process, see https://
www2.epa.gov/pesticide-science-andassessing-pesticide-risks/assessinghuman-health-risk-pesticides.
A summary of the toxicological
endpoints for mandipropamid used for
human risk assessment is shown in
Table 1 of this unit.
E:\FR\FM\22MRR1.SGM
22MRR1
Federal Register / Vol. 84, No. 56 / Friday, March 22, 2019 / Rules and Regulations
10697
TABLE 1—SUMMARY OF TOXICOLOGICAL DOSES AND ENDPOINTS FOR MANDIPROPAMID FOR USE IN HUMAN HEALTH RISK
ASSESSMENT
Point of departure and
uncertainty/safety factors
Exposure/scenario
Acute dietary(All populations, including infants
and children, and females 13–49).
Chronic dietary (All populations) ......................
RfD, PAD, LOC for
risk assessment
Study and toxicological effects
No appropriate endpoint for a single exposure was identified in the database.
NOAEL= 5 mg/kg/day ............
UFA = 10x
UFH = 10x
FQPA SF = 1x
Cancer (Oral, dermal, inhalation) .....................
Chronic RfD = 0.05 mg/kg/day
cPAD = 0.05 mg/kg/day
Chronic toxicity study—dog.
LOAEL = 40 mg/kg/day,
based on increased incidence and severity of microscopic pigment in the
liver, and increased alkaline
phosphatase activity in both
sexes, as well as increased
alanine aminotransferase
activity in males.
Classified as not likely to be carcinogenic to humans.
FQPA SF = Food Quality Protection Act Safety Factor. LOAEL = lowest-observed-adverse-effect-level. mg/kg/day = milligram/kilogram/day.
NOAEL = no-observed-adverse-effect-level. PAD = population adjusted dose (a = acute, c = chronic). RfD = reference dose. UF = uncertainty
factor. UFA = extrapolation from animal to human (interspecies). UFH = potential variation in sensitivity among members of the human population
(intraspecies).
C. Exposure Assessment
1. Dietary exposure from food and
feed uses. In evaluating dietary
exposure to mandipropamid, EPA
considered exposure under the
petitioned-for tolerances as well as all
existing mandipropamid tolerances in
40 CFR 180.637. EPA assessed dietary
exposures from mandipropamid in food
as follows:
i. Acute exposure. Quantitative acute
dietary exposure and risk assessments
are performed for a food-use pesticide,
if a toxicological study has indicated the
possibility of an effect of concern
occurring as a result of a 1-day or single
exposure. No such effects were
identified in the toxicological studies
for mandipropamid; therefore, a
quantitative acute dietary exposure
assessment is unnecessary.
ii. Chronic exposure. In conducting
the chronic dietary exposure
assessment, EPA used Dietary Exposure
Evaluation Model software with the
Food Commodity Intake Database
(DEEM–FCID) Version 3.16, which uses
food consumption data from the U.S.
Department of Agriculture’s (USDA’s)
National Health and Nutrition
Examination Survey, ‘‘What We Eat in
America’’ (NHANES/WWEIA) from
2003 through 2008. As to residue levels
in food, the chronic dietary risk
assessment assumed tolerance-level
residues in all commodities with
existing tolerances except tuberous and
corm vegetable subgroup 1C. For the
chronic dietary risk assessment, this
subgroup was assessed at 0.115 ppm,
which assumes tolerance-level residues
of parent mandipropamid (0.09 ppm),
and includes metabolite SYN 500003 in
parent-equivalents (at 0.025 ppm).
VerDate Sep<11>2014
17:21 Mar 21, 2019
Jkt 247001
Tolerance-level residues associated with
the proposed new uses and crop group
conversions were also used in the
assessment. The Agency’s 2018 Default
Processing Factors were used for all
processed commodities for which they
were available. The empirical
processing factor from the grape
processing study was used for grape
wine/sherry (1.5X). A processing factor
was not used for grape raisin because a
tolerance is currently established in
raisin. Similarly, processing factors
were not used for citrus oil and dried
pulp because the Agency is establishing
separate tolerances in these
commodities.
iii. Cancer. Based on the lack of
evidence of carcinogenicity or
genotoxicity, the Agency has classified
mandipropamid as ‘‘not likely to be a
human carcinogen’’ and therefore, there
is no concern for cancer risk.
iv. Anticipated residue and percent
crop treated (PCT) information. EPA did
not use anticipated residue or PCT
information in the dietary assessment
for mandipropamid. Tolerance level
residues and 100 PCT were assumed for
all food commodities except as noted in
section III.C.ii.
2. Dietary exposure from drinking
water. The Agency used screening level
water exposure models in the dietary
exposure analysis and risk assessment
for mandipropamid in drinking water.
These simulation models take into
account data on the physical, chemical,
and fate/transport characteristics of
mandipropamid. Further information
regarding EPA drinking water models
used in pesticide exposure assessment
can be found at https://www2.epa.gov/
pesticide-science-and-assessing-
PO 00000
Frm 00033
Fmt 4700
Sfmt 4700
pesticide-risks/about-water-exposuremodels-used-pesticide.
Based on the FQPA Index Reservoir
Screening Tool (FIRST) and Pesticide
Root Zone Model Ground Water (PRZM
GW), the estimated drinking water
concentrations (EDWCs) of
mandipropamid for chronic exposures
are estimated to be 9.0 ppb for surface
water and 79 ppb for ground water.
Modeled estimates of drinking water
concentrations were directly entered
into the dietary exposure model. For the
chronic dietary risk assessment, the
water concentration value of 79 ppb was
used to assess the contribution to
drinking water.
3. From non-dietary exposure. The
term ‘‘residential exposure’’ is used in
this document to refer to nonoccupational, non-dietary exposure
(e.g., for lawn and garden pest control,
indoor pest control, termiticides, and
flea and tick control on pets).
Mandipropamid is not registered for
any specific use patterns that would
result in residential exposure.
4. Cumulative effects from substances
with a common mechanism of toxicity.
Section 408(b)(2)(D)(v) of FFDCA
requires that, when considering whether
to establish, modify, or revoke a
tolerance, the Agency consider
‘‘available information’’ concerning the
cumulative effects of a particular
pesticide’s residues and ‘‘other
substances that have a common
mechanism of toxicity.’’
EPA has not found mandipropamid to
share a common mechanism of toxicity
with any other substances, and
mandipropamid does not appear to
produce a toxic metabolite produced by
other substances. For the purposes of
this tolerance action, therefore, EPA has
E:\FR\FM\22MRR1.SGM
22MRR1
10698
Federal Register / Vol. 84, No. 56 / Friday, March 22, 2019 / Rules and Regulations
assumed that mandipropamid does not
have a common mechanism of toxicity
with other substances. For information
regarding EPA’s efforts to determine
which chemicals have a common
mechanism of toxicity and to evaluate
the cumulative effects of such
chemicals, see EPA’s website at https://
www2.epa.gov/pesticide-science-andassessing-pesticide-risks/cumulativeassessment-risk-pesticides.
D. Safety Factor for Infants and
Children
1. In general. Section 408(b)(2)(C) of
FFDCA provides that EPA shall apply
an additional tenfold (10X) margin of
safety for infants and children in the
case of threshold effects to account for
prenatal and postnatal toxicity and the
completeness of the database on toxicity
and exposure unless EPA determines
based on reliable data that a different
margin of safety will be safe for infants
and children. This additional margin of
safety is commonly referred to as the
FQPA Safety Factor (SF). In applying
this provision, EPA either retains the
default value of 10X, or uses a different
additional safety factor when reliable
data available to EPA support the choice
of a different factor.
2. Prenatal and postnatal sensitivity.
No evidence of increased pre- or
postnatal quantitative or qualitative
susceptibility was observed. No fetal or
maternal toxicity was observed in
developmental toxicity studies in the rat
and rabbit. Decreased pup weights were
observed in the rat two-generation
reproduction study in the presence of
decreased parental body weight and
food utilization.
3. Conclusion. EPA has determined
that reliable data show the safety of
infants and children would be
adequately protected if the FQPA SF
were reduced to 1x. That decision is
based on the following findings:
i. The toxicity database for
mandipropamid is complete.
ii. There is no indication that
mandipropamid is a neurotoxic
chemical and there is no need for a
developmental neurotoxicity study or
additional UFs to account for
neurotoxicity.
iii. There is no evidence that
mandipropamid results in increased
susceptibility in in utero rats or rabbits
in the prenatal developmental studies or
in young rats in the 2-generation
reproduction study.
iv. There are no residual uncertainties
identified in the exposure databases.
The dietary food exposure assessments
were performed based on 100 PCT and
tolerance-level residues except as noted
in section III.C.ii. EPA made
VerDate Sep<11>2014
16:22 Mar 21, 2019
Jkt 247001
conservative (protective) assumptions in
the ground and surface water modeling
used to assess exposure to
mandipropamid in drinking water.
These assessments will not
underestimate the exposure and risks
posed by mandipropamid.
E. Aggregate Risks and Determination of
Safety
EPA determines whether acute and
chronic dietary pesticide exposures are
safe by comparing aggregate exposure
estimates to the acute PAD (aPAD) and
chronic PAD (cPAD). For linear cancer
risks, EPA calculates the lifetime
probability of acquiring cancer given the
estimated aggregate exposure. Short-,
intermediate-, and chronic-term risks
are evaluated by comparing the
estimated aggregate food, water, and
residential exposure to the appropriate
PODs to ensure that an adequate MOE
exists.
1. Acute risk. An acute aggregate risk
assessment takes into account acute
exposure estimates from dietary
consumption of food and drinking
water. No adverse effect resulting from
a single oral exposure was identified
and no acute dietary endpoint was
selected. Therefore, mandipropamid is
not expected to pose an acute risk.
2. Chronic risk. Using the exposure
assumptions described in this unit for
chronic exposure, EPA has concluded
that chronic exposure to
mandipropamid from food and water
will utilize 49% of the cPAD for
children 1–2 years old, the population
group receiving the greatest exposure.
There are no residential uses for
mandipropamid.
3. Short- and intermediate-term risk.
Short- and intermediate-term aggregate
exposure takes into account short- and
intermediate-term residential exposure
plus chronic exposure to food and water
(considered to be a background
exposure level). Short- and
intermediate-term adverse effects were
identified; however, mandipropamid is
not registered for any use patterns that
would result in either short- or
intermediate-term residential exposure.
Short- and intermediate-term risk is
assessed based on short- and
intermediate-term residential exposure
plus chronic dietary exposure. Because
there is no short- or intermediate-term
residential exposure and chronic dietary
exposure has already been assessed
under the appropriately protective
cPAD (which is at least as protective as
the POD used to assess short-term risk),
no further assessment of short- or
intermediate-term risk is necessary, and
EPA relies on the chronic dietary risk
assessment for evaluating short- and
PO 00000
Frm 00034
Fmt 4700
Sfmt 4700
intermediate-term risk for
mandipropamid.
4. Aggregate cancer risk for U.S.
population. Based on the lack of
evidence of carcinogenicity in two
adequate rodent carcinogenicity studies,
mandipropamid is not expected to pose
a cancer risk to humans.
5. Determination of safety. Based on
these risk assessments, EPA concludes
that there is a reasonable certainty that
no harm will result to the general
population, or to infants and children
from aggregate exposure to
mandipropamid residues.
IV. Other Considerations
A. Analytical Enforcement Methodology
There is an adequate enforcement
method available for the quantitation of
mandipropamid in plant commodities.
Method RAM 415/01, using high
performance liquid chromatography
with tandem mass spectrometric
detection (LC/MS/MS), has been
adequately validated by an independent
laboratory. It has a validated limit of
quantitation (LOQ) of 0.01 ppm. An
acceptable confirmatory method is also
available.
The method may be requested from:
Chief, Analytical Chemistry Branch,
Environmental Science Center, 701
Mapes Rd., Ft. Meade, MD 20755–5350;
telephone number: (410) 305–2905;
email address: residuemethods@
epa.gov.
B. International Residue Limits
In making its tolerance decisions, EPA
seeks to harmonize U.S. tolerances with
international standards whenever
possible, consistent with U.S. food
safety standards and agricultural
practices. EPA considers the
international maximum residue limits
(MRLs) established by the Codex
Alimentarius Commission (Codex), as
required by FFDCA section 408(b)(4).
The Codex Alimentarius is a joint
United Nations Food and Agriculture
Organization/World Health
Organization food standards program,
and it is recognized as an international
food safety standards-setting
organization in trade agreements to
which the United States is a party. EPA
may establish a tolerance that is
different from a Codex MRL; however,
FFDCA section 408(b)(4) requires that
EPA explain the reasons for departing
from the Codex level.
There are no harmonization issues
with Codex regarding the new use on
citrus fruits because Codex has not
established MRLs for mandipropamid in
citrus commodities. Additionally,
Codex has not established an MRL in
E:\FR\FM\22MRR1.SGM
22MRR1
Federal Register / Vol. 84, No. 56 / Friday, March 22, 2019 / Rules and Regulations
snap beans, so this is not a
harmonization issue. Regarding the
updated crop group/subgroup
conversions, the tolerance in leafy
vegetable group 4–16 is harmonized
with the corresponding Codex MRLs.
The tolerance in Brassica head and stem
vegetable group 5–16, and the
individual tolerance in kohlrabi, is
harmonized with the Codex MRLs in
cabbage and Chinese napa cabbage, but
not the Codex MRL in broccoli. There
are no Codex MRLs in Brussels sprouts,
cauliflower or kohlrabi. The EPA is not
harmonizing with the Codex MRL in
broccoli because it is lower than the
U.S. tolerance in Brassica head and
stem vegetable group 5–16; setting a
lower tolerance in broccoli could result
in violative residues for U.S. growers.
The tolerance in leaf petiole subgroup
22B, with individual tolerances in
celtuce and Florence fennel, is
harmonized with the Codex MRL in
celery.
C. Revisions to Petitioned-For
Tolerances
EPA’s tolerance levels are expressed
to provide sufficient precision for
enforcement purposes, and this may
include the addition of trailing zeros
(0.50 ppm rather than the proposed 0.5
ppm). The Agency does this in order to
avoid the situation where rounding of
an observed violative residue to the
level of precision of the tolerance
expression would result in a residue
being considered non-violative (such as
0.54 ppm being rounded to 0.5 ppm).
EPA made this revision for Fruit, citrus,
group 10–10, Kohlrabi, and Vegetable,
Brassica, head and stem, group 5–16.
Because the petitioner proposed
separate tolerances in both subgroups 4–
16A and 4–16B at 25 ppm, the Agency
is establishing a single tolerance in leafy
vegetable group 4–16 at 25 ppm rather
than separate tolerances in the two
subgroups. In addition, the Agency
revised the commodity terminology to
use the correct commodity definition for
Florence fennel, which is Fennel,
Florence, fresh leaves and stalk.
The proposed tolerance in citrus dried
pulp (0.14 ppm) was incorrectly based
on the dried pulp processing factor
(2.9X) multiplied by the lowest average
field trial value (LAFT) of 0.049 ppm
from the orange field trials. However,
per Office of Chemical Safety and
Pollution Prevention (OCSPP) Residue
Chemistry Test Guideline 860.1520,
EPA based the tolerance on the
processing factor (2.9X) multiplied by
the highest average field trial value
(HAFT) of 0.231 ppm from the lemon
field trials (which had the highest HAFT
of the three representative
VerDate Sep<11>2014
16:22 Mar 21, 2019
Jkt 247001
commodities), yielding a result of 0.67
ppm. Per the rounding protocol in the
Organization for Economic Cooperation
and Development (OECD) MRL
Calculator User Guide, this result was
increased to 0.70 ppm.
Similarly, the proposed tolerance in
citrus oil (2.2 ppm) was incorrectly
based on the oil processing factor (45X)
multiplied by the LAFT of 0.049 ppm
from the orange field trials. As for dried
pulp, EPA based the tolerance in citrus
oil on the processing factor (45X)
multiplied by the HAFT of 0.231 ppm
from the lemon field trials, yielding a
result of 10.4 ppm. Per the rounding
protocol in the OECD’s MRL Calculator
User Guide this result was increased to
15 ppm.
V. Conclusion
Therefore, tolerances are established
for residues of mandipropamid in or on
Asparagus bean, edible podded at 0.90
ppm; Bean (Phaseolus spp.), edible
podded at 0.90 ppm; Bean (Vigna spp.),
edible podded at 0.90 ppm; Catjang
bean, edible podded at 0.90 ppm;
Celtuce at 20 ppm; Chinese longbean,
edible podded at 0.90 ppm; Citrus, dried
pulp at 0.70 ppm; Citrus, oil at 15 ppm;
Cowpea, edible podded at 0.90 ppm;
Fennel, Florence, fresh leaves and stalk
at 20 ppm; French bean, edible podded
at 0.90 ppm; Fruit, citrus, group 10–10
at 0.50 ppm; Garden bean, edible
podded at 0.90 ppm; Goa bean, edible
podded at 0.90 ppm; Green bean, edible
podded at 0.90 ppm; Guar bean, edible
podded at 0.90 ppm; Jackbean, edible
podded at 0.90 ppm; Kidney bean,
edible podded at 0.90 ppm; Kohlrabi at
3.0 ppm; Lablab bean, edible podded at
0.90 ppm; Leaf petiole vegetable
subgroup 22B at 20 ppm; Moth bean,
edible podded at 0.90 ppm; Mung bean,
edible podded at 0.90 ppm; Navy bean,
edible podded at 0.90 ppm; Rice bean,
edible podded at 0.90 ppm; Scarlet
runner bean, edible podded at 0.90
ppm; Snap bean, edible podded at 0.90
ppm; Sword bean, edible podded at 0.90
ppm; Urd bean, edible podded at 0.90
ppm; Vegetable, Brassica, head and
stem, group 5–16 at 3.0 ppm; Vegetable,
leafy, group 4–16 at 25 ppm; Vegetable
soybean, edible podded at 0.90 ppm;
Velvet bean, edible podded at 0.90 ppm;
Wax bean, edible podded at 0.90 ppm;
Winged pea, edible podded at 0.90 ppm;
and Yardlong bean, edible podded at
0.90 ppm.
Additionally, the existing tolerances
in/on Bean, snap at 0.90 ppm; Brassica,
head and stem, subgroup 5A at 3 ppm;
Brassica, leafy greens, subgroup 5B at 25
ppm; and Vegetable, leafy except
Brassica, group 4 at 20 ppm are
PO 00000
Frm 00035
Fmt 4700
Sfmt 4700
10699
removed as unnecessary since they are
covered by the new tolerances.
VI. Statutory and Executive Order
Reviews
This action establishes tolerances
under FFDCA section 408(d) in
response to a petition submitted to the
Agency. The Office of Management and
Budget (OMB) has exempted these types
of actions from review under Executive
Order 12866, entitled ‘‘Regulatory
Planning and Review’’ (58 FR 51735,
October 4, 1993). Because this action
has been exempted from review under
Executive Order 12866, this action is
not subject to Executive Order 13211,
entitled ‘‘Actions Concerning
Regulations That Significantly Affect
Energy Supply, Distribution, or Use’’ (66
FR 28355, May 22, 2001) or Executive
Order 13045, entitled ‘‘Protection of
Children from Environmental Health
Risks and Safety Risks’’ (62 FR 19885,
April 23, 1997), nor is it considered a
regulatory action under Executive Order
13771, entitled ‘‘Reducing Regulations
and Controlling Regulatory Costs’’ (82
FR 9339, February 3, 2017). This action
does not contain any information
collections subject to OMB approval
under the Paperwork Reduction Act
(PRA) (44 U.S.C. 3501 et seq.), nor does
it require any special considerations
under Executive Order 12898, entitled
‘‘Federal Actions to Address
Environmental Justice in Minority
Populations and Low-Income
Populations’’ (59 FR 7629, February 16,
1994).
Since tolerances and exemptions that
are established on the basis of a petition
under FFDCA section 408(d), such as
the tolerances in this final rule, do not
require the issuance of a proposed rule,
the requirements of the Regulatory
Flexibility Act (RFA) (5 U.S.C. 601 et
seq.), do not apply.
This action directly regulates growers,
food processors, food handlers, and food
retailers, not States or tribes, nor does
this action alter the relationships or
distribution of power and
responsibilities established by Congress
in the preemption provisions of FFDCA
section 408(n)(4). As such, the Agency
has determined that this action will not
have a substantial direct effect on States
or tribal governments, on the
relationship between the national
government and the States or tribal
governments, or on the distribution of
power and responsibilities among the
various levels of government or between
the Federal Government and Indian
tribes. Thus, the Agency has determined
that Executive Order 13132, entitled
‘‘Federalism’’ (64 FR 43255, August 10,
1999) and Executive Order 13175,
E:\FR\FM\22MRR1.SGM
22MRR1
10700
Federal Register / Vol. 84, No. 56 / Friday, March 22, 2019 / Rules and Regulations
entitled ‘‘Consultation and Coordination
with Indian Tribal Governments’’ (65 FR
67249, November 9, 2000) do not apply
to this action. In addition, this action
does not impose any enforceable duty or
contain any unfunded mandate as
described under Title II of the Unfunded
Mandates Reform Act (UMRA) (2 U.S.C.
1501 et seq.).
This action does not involve any
technical standards that would require
Agency consideration of voluntary
consensus standards pursuant to section
12(d) of the National Technology
Transfer and Advancement Act
(NTTAA) (15 U.S.C. 272 note).
VII. Congressional Review Act
Pursuant to the Congressional Review
Act (5 U.S.C. 801 et seq.), EPA will
submit a report containing this rule and
other required information to the U.S.
Senate, the U.S. House of
Representatives, and the Comptroller
General of the United States prior to
publication of the rule in the Federal
Register. This action is not a ‘‘major
rule’’ as defined by 5 U.S.C. 804(2).
List of Subjects in 40 CFR Part 180
Environmental protection,
Administrative practice and procedure,
Agricultural commodities, Pesticides
and pests, Reporting and recordkeeping
requirements.
Dated: March 14, 2019.
Michael Goodis,
Director, Registration Division, Office of
Pesticide Programs.
Therefore, 40 CFR chapter I is
amended as follows:
PART 180—[AMENDED]
1. The authority citation for part 180
continues to read as follows:
■
Authority: 21 U.S.C. 321(q), 346a and 371.
2. In § 180.637, in the table to
paragraph (a):
■ a. Add alphabetically the entry
‘‘Asparagus bean, edible podded’’;
■ b. Remove the entry for ‘‘Bean, snap’’;
■ c. Add alphabetically the entries
‘‘Bean (Phaseolus spp.), edible podded’’
and ‘‘Bean (Vigna spp.), edible podded’’;
■ d. Remove the entries for ‘‘Brassica,
head and stem, subgroup 5A’’ and
‘‘Brassica, leafy greens, subgroup 5B’’;
and
■ e. Add alphabetically the entries
‘‘Catjang bean, edible podded’’;
‘‘Celtuce’’; ‘‘Chinese longbean, edible
podded’’; ‘‘Citrus, dried pulp’’; ‘‘Citrus,
oil’’; ‘‘Cowpea, edible podded’’;
‘‘Fennel, Florence, fresh leaves and
stalk’’; ‘‘French bean, edible podded’’;
‘‘Fruit, citrus, group 10–10’’; ‘‘Garden
bean, edible podded’’; ‘‘Goa bean, edible
■
VerDate Sep<11>2014
16:22 Mar 21, 2019
Jkt 247001
podded’’; ‘‘Green bean, edible podded’’;
‘‘Guar bean, edible podded’’; ‘‘Jackbean,
edible podded’’; ‘‘Kidney bean, edible
podded’’; ‘‘Kohlrabi’’; ‘‘Lablab bean,
edible podded’’; ‘‘Leaf petiole vegetable
subgroup 22B’’; ‘‘Moth bean, edible
podded’’; ‘‘Mung bean, edible podded’’;
‘‘Navy bean, edible podded’’; ‘‘Rice
bean, edible podded’’; ‘‘Scarlet runner
bean, edible podded’’; ‘‘Snap bean,
edible podded’’; ‘‘Sword bean, edible
podded’’; ‘‘Urd bean, edible podded’’;
‘‘Vegetable, Brassica, head and stem,
group 5–16’’; and ‘‘Vegetable, leafy,
group 4–16’’;
■ f. Remove the entry for ‘‘Vegetable,
leafy except Brassica, group 4’’; and
■ g. Add alphabetically the entries
‘‘Vegetable soybean, edible podded’’;
‘‘Velvet bean, edible podded’’; ‘‘Wax
bean, edible podded’’; ‘‘Winged pea,
edible podded’’; and ‘‘Yardlong bean,
edible podded’’.
The additions read as follows:
§ 180.637 Mandipropamid; tolerances for
residues.
(a) * * *
Parts per
million
Commodity
Parts per
million
Commodity
Scarlet runner bean, edible podded ..........................................
Snap bean, edible podded .........
Sword bean, edible podded .......
Urd bean, edible podded ............
Vegetable, Brassica, head and
stem, group 5–16 ....................
0.90
*
*
*
*
Velvet bean, edible podded ........
Wax bean, edible podded ..........
Winged pea, edible podded .......
Yardlong bean, edible podded ...
*
0.90
0.90
0.90
0.90
*
*
*
*
BILLING CODE 6560–50–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Medicare & Medicaid
Services
*
*
*
*
Bean (Phaseolus spp.), edible
podded ....................................
Bean (Vigna spp.), edible podded ..........................................
Catjang bean, edible podded .....
Celtuce ........................................
Chinese longbean, edible podded ..........................................
Citrus, dried pulp ........................
Citrus, oil .....................................
Cowpea, edible podded ..............
Fennel, Florence, fresh leaves
and stalk ..................................
French bean, edible podded ......
Fruit, citrus, group 10–10 ...........
*
Office of Inspector General
0.90
42 CFR Part 1007
0.90
0.90
20
RIN 0936–AA07
*
0.90
*
*
*
*
Goa bean, edible podded ...........
*
0.90
*
*
*
*
Green bean, edible podded ........
Guar bean, edible podded ..........
*
0.90
0.90
*
*
*
*
Jackbean, edible podded ...........
Kidney bean, edible podded .......
Kohlrabi .......................................
Lablab bean, edible podded .......
Leaf petiole vegetable subgroup
22B ..........................................
Moth bean, edible podded ..........
Mung bean, edible podded .........
Navy bean, edible podded .........
*
0.90
0.90
3.0
0.90
*
*
*
*
Rice bean, edible podded ..........
*
0.90
PO 00000
Frm 00036
Fmt 4700
Sfmt 4700
20
0.90
0.90
0.90
25
*
42 CFR Part 455
*
*
*
*
Garden bean, edible podded ......
*
[FR Doc. 2019–05406 Filed 3–21–19; 8:45 am]
0.90
20
0.90
0.50
3.0
*
*
*
*
Vegetable, leafy, group 4–16 .....
Vegetable soybean, edible podded ..........................................
Asparagus bean, edible podded
0.90
0.70
15
0.90
0.90
0.90
0.90
0.90
Medicaid; Revisions to State Medicaid
Fraud Control Unit Rules
Office of Inspector General
(OIG) and Centers for Medicare &
Medicaid Services (CMS), Department
of Health and Human Services (HHS).
ACTION: Final rule.
AGENCIES:
This final rule amends the
regulation governing State Medicaid
Fraud Control Units (MFCUs or Units).
The rule incorporates statutory changes
affecting the Units as well as policy and
practice changes that have occurred
since the regulation was initially issued
in 1978. These changes include a
recognition of OIG’s delegated authority;
Unit authority, functions, and
responsibilities; disallowances; and
issues related to organization,
prosecutorial authority, staffing,
recertification, and the Units’
relationship with Medicaid agencies.
The rule is designed to assist the
MFCUs in understanding their
authorities and responsibilities under
the grant program, clarify the
flexibilities the MFCUs have to operate
their programs, and reduce
administrative burden, where
SUMMARY:
E:\FR\FM\22MRR1.SGM
22MRR1
Agencies
[Federal Register Volume 84, Number 56 (Friday, March 22, 2019)]
[Rules and Regulations]
[Pages 10695-10700]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2019-05406]
[[Page 10695]]
-----------------------------------------------------------------------
ENVIRONMENTAL PROTECTION AGENCY
40 CFR Part 180
[EPA-HQ-OPP-2017-0671; FRL-9987-25]
Mandipropamid; Pesticide Tolerances
AGENCY: Environmental Protection Agency (EPA).
ACTION: Final rule.
-----------------------------------------------------------------------
SUMMARY: This regulation establishes tolerances for residues of
mandipropamid in or on multiple commodities which are identified and
discussed later in this document. Interregional Research Project Number
4 (IR-4) requested these tolerances under the Federal Food, Drug, and
Cosmetic Act (FFDCA).
DATES: This regulation is effective March 22, 2019. Objections and
requests for hearings must be received on or before May 21, 2019, and
must be filed in accordance with the instructions provided in 40 CFR
part 178 (see also Unit I.C. of the SUPPLEMENTARY INFORMATION).
ADDRESSES: The docket for this action, identified by docket
identification (ID) number EPA-HQ-OPP-2017-0671, is available at https://www.regulations.gov or at the Office of Pesticide Programs Regulatory
Public Docket (OPP Docket) in the Environmental Protection Agency
Docket Center (EPA/DC), West William Jefferson Clinton Bldg., Rm. 3334,
1301 Constitution Ave. NW, Washington, DC 20460-0001. The Public
Reading Room is open from 8:30 a.m. to 4:30 p.m., Monday through
Friday, excluding legal holidays. The telephone number for the Public
Reading Room is (202) 566-1744, and the telephone number for the OPP
Docket is (703) 305-5805. Please review the visitor instructions and
additional information about the docket available at https://www.epa.gov/dockets.
FOR FURTHER INFORMATION CONTACT: Michael Goodis, Registration Division
(7505P), Office of Pesticide Programs, Environmental Protection Agency,
1200 Pennsylvania Ave. NW, Washington, DC 20460-0001; main telephone
number: (703) 305-7090; email address: RDFRNotices@epa.gov.
SUPPLEMENTARY INFORMATION:
I. General Information
A. Does this action apply to me?
You may be potentially affected by this action if you are an
agricultural producer, food manufacturer, or pesticide manufacturer.
The following list of North American Industrial Classification System
(NAICS) codes is not intended to be exhaustive, but rather provides a
guide to help readers determine whether this document applies to them.
Potentially affected entities may include:
Crop production (NAICS code 111).
Animal production (NAICS code 112).
Food manufacturing (NAICS code 311).
Pesticide manufacturing (NAICS code 32532).
B. How can I get electronic access to other related information?
You may access a frequently updated electronic version of EPA's
tolerance regulations at 40 CFR part 180 through the Government
Printing Office's e-CFR site at https://www.ecfr.gov/cgi-bin/text-idx?&c=ecfr&tpl=/ecfrbrowse/Title40/40tab_02.tpl.
C. How can I file an objection or hearing request?
Under FFDCA section 408(g), 21 U.S.C. 346a, any person may file an
objection to any aspect of this regulation and may also request a
hearing on those objections. You must file your objection or request a
hearing on this regulation in accordance with the instructions provided
in 40 CFR part 178. To ensure proper receipt by EPA, you must identify
docket ID number EPA-HQ-OPP-2017-0671 in the subject line on the first
page of your submission. All objections and requests for a hearing must
be in writing, and must be received by the Hearing Clerk on or before
May 21, 2019. Addresses for mail and hand delivery of objections and
hearing requests are provided in 40 CFR 178.25(b).
In addition to filing an objection or hearing request with the
Hearing Clerk as described in 40 CFR part 178, please submit a copy of
the filing (excluding any Confidential Business Information (CBI)) for
inclusion in the public docket. Information not marked confidential
pursuant to 40 CFR part 2 may be disclosed publicly by EPA without
prior notice. Submit the non-CBI copy of your objection or hearing
request, identified by docket ID number EPA-HQ-OPP-2017-0671, by one of
the following methods:
Federal eRulemaking Portal: https://www.regulations.gov.
Follow the online instructions for submitting comments. Do not submit
electronically any information you consider to be CBI or other
information whose disclosure is restricted by statute.
Mail: OPP Docket, Environmental Protection Agency Docket
Center (EPA/DC), (28221T), 1200 Pennsylvania Ave. NW, Washington, DC
20460-0001.
Hand Delivery: To make special arrangements for hand
delivery or delivery of boxed information, please follow the
instructions at https://www.epa.gov/dockets/contacts.html.
Additional instructions on commenting or visiting the docket, along
with more information about dockets generally, is available at https://www.epa.gov/dockets.
II. Summary of Petitioned-For Tolerance
In the Federal Register of July 24, 2018 (83 FR 34968) (FRL-9980-
31), EPA issued a document pursuant to FFDCA section 408(d)(3), 21
U.S.C. 346a(d)(3), announcing the filing of a pesticide petition (PP
7E8629) by IR-4, IR-4 Project Headquarters, Rutgers, The State
University of NJ, 500 College Road East, Suite 201W, Princeton, NJ
08540. The petition requested that 40 CFR part 180 be amended by
establishing tolerances for residues of mandipropamid, 4-chloro-N-[2-
(3-methoxy-4-(2-propynyloxy)phenyl]ethyl]-[alpha]-(2-propynyloxy)-
benzeneacetamide], in or on the raw agricultural commodities: Asparagus
bean, edible podded at 0.90 parts per million (ppm); Bean (Phaseolus
spp.), edible podded at 0.90 ppm; Bean (Vigna spp.), edible podded at
0.90 ppm; Brassica, leafy greens, subgroup 4-16B at 25 ppm; Catjang
bean, edible podded at 0.90 ppm; Celtuce at 20 ppm; Chinese longbean,
edible podded at 0.90 ppm; Citrus, dried pulp at 0.14 ppm; Citrus, oil
at 2.2 ppm; Cowpea, edible podded at 0.90 ppm; Florence fennel at 20
ppm; French bean, edible podded at 0.90 ppm; Fruit, citrus, group 10-10
at 0.5 ppm; Garden bean, edible podded at 0.90 ppm; Goa bean, edible
podded at 0.90 ppm; Green bean, edible podded at 0.90 ppm; Guar bean,
edible podded at 0.90 ppm; Jackbean, edible podded at 0.90 ppm; Kidney
bean, edible podded at 0.90 ppm; Kohlrabi at 3 ppm; Lablab bean, edible
podded at 0.90 ppm; Leaf petiole vegetable subgroup 22B at 20 ppm;
Leafy greens subgroup 4-16A at 25 ppm; Moth bean, edible podded at 0.90
ppm; Mung bean, edible podded at 0.90 ppm; Navy bean, edible podded at
0.90 ppm; Rice bean, edible podded at 0.90 ppm; Scarlet runner bean,
edible podded at 0.90 ppm; Snap bean, edible podded at 0.90 ppm; Sword
bean, edible podded at 0.90 ppm; Urd bean, edible podded at 0.90 ppm;
Vegetable soybean, edible podded at 0.90 ppm; Vegetable, Brassica, head
and stem, group 5-16 at
[[Page 10696]]
3 ppm; Velvet bean, edible podded at 0.90 ppm; Wax bean, edible podded
at 0.90 ppm; Winged pea, edible podded at 0.90 ppm; and Yardlong bean,
edible podded at 0.90 ppm.
Additionally, the petition requested to amend 40 CFR 180.637 by
removing the tolerances for residues of mandipropamid in or on the raw
agricultural commodities Bean, snap at 0.90 ppm; Brassica, head and
stem, subgroup 5A at 3 ppm; Brassica, leafy greens, subgroup 5B at 25
ppm; and Vegetable, leafy except Brassica, group 4 at 20 ppm.
That document referenced a summary of the petition prepared by
Syngenta Crop Protection, the registrant, which is available in the
docket, https://www.regulations.gov. There were no comments received in
response to the notice of filing.
Based upon review of the data supporting the petition, EPA has
modified the levels at which some tolerances are being established as
well as some of the commodities in which tolerances are being
established. The reason for these changes are explained in Unit IV.C.
III. Aggregate Risk Assessment and Determination of Safety
Section 408(b)(2)(A)(i) of FFDCA allows EPA to establish a
tolerance (the legal limit for a pesticide chemical residue in or on a
food) only if EPA determines that the tolerance is ``safe.'' Section
408(b)(2)(A)(ii) of FFDCA defines ``safe'' to mean that ``there is a
reasonable certainty that no harm will result from aggregate exposure
to the pesticide chemical residue, including all anticipated dietary
exposures and all other exposures for which there is reliable
information.'' This includes exposure through drinking water and in
residential settings, but does not include occupational exposure.
Section 408(b)(2)(C) of FFDCA requires EPA to give special
consideration to exposure of infants and children to the pesticide
chemical residue in establishing a tolerance and to ``ensure that there
is a reasonable certainty that no harm will result to infants and
children from aggregate exposure to the pesticide chemical residue . .
. .''
Consistent with FFDCA section 408(b)(2)(D), and the factors
specified in FFDCA section 408(b)(2)(D), EPA has reviewed the available
scientific data and other relevant information in support of this
action. EPA has sufficient data to assess the hazards of and to make a
determination on aggregate exposure for mandipropamid including
exposure resulting from the tolerances established by this action.
EPA's assessment of exposures and risks associated with mandipropamid
follows.
A. Toxicological Profile
EPA has evaluated the available toxicity data and considered its
validity, completeness, and reliability as well as the relationship of
the results of the studies to human risk. EPA has also considered
available information concerning the variability of the sensitivities
of major identifiable subgroups of consumers, including infants and
children.
Subchronic and chronic studies indicate that the liver and kidney
are the primary target organs for mandipropamid. Liver effects observed
in subchronic studies with rats, mice and dogs included periportal
hypertrophy (rats), increased eosinophilia (rats and mice), increased
plasma albumin, total protein, cholesterol, and gamma-glutamyl
transferase (rats), increased liver weights (rats, mice and dogs),
increased liver enzymes (dogs), increased pigment in hepatocytes and
Kupffer cells (dogs), and centrilobular hepatocyte vacuolation (dogs).
In the chronic dog study, increases in microscopic pigment in the
liver, and increased liver enzymes were observed. In the chronic rat
and mouse studies, liver toxicity was not observed. Nephrotoxicity was
observed in the chronic rat study; however, in the chronic mouse study,
only decreased body weight and food utilization were observed. The
findings of liver toxicity and nephrotoxicity are consistent with the
results from metabolism studies, in which radioactivity levels in liver
and kidney were typically higher than other tissues. There were no
consistent sex-related differences in target organ toxicity, although
male rats appeared to be more sensitive to body weight effects.
No evidence of neurotoxicity was observed in the database,
including rat acute or subchronic neurotoxicity studies. No systemic or
dermal toxicity was observed in the rat following dermal exposure for
28 days up to the limit dose.
No evidence of increased pre- or postnatal quantitative or
qualitative susceptibility was observed. No fetal or maternal toxicity
was observed in developmental toxicity studies in the rat and rabbit.
Decreased pup weights were observed in the rat two-generation
reproduction study in the presence of decreased parental body weight
and food utilization.
There was no evidence of a treatment-related increase in tumor
incidence in the mouse carcinogenicity study or the rat chronic/
carcinogenicity study. There was no evidence of genotoxicity in
bacterial reverse gene mutation, mammalian in vitro forward gene
mutation, mammalian in vivo clastogenicity, or unscheduled DNA
synthesis assays. Therefore, mandipropamid is classified as ``not
likely to be carcinogenic to humans.''
Specific information on the studies received and the nature of the
adverse effects caused by mandipropamid as well as the no-observed-
adverse-effect-level (NOAEL) and the lowest-observed-adverse-effect-
level (LOAEL) from the toxicity studies can be found at https://www.regulations.gov in the document titled ``Mandipropamid. Aggregate
Human Health Risk Assessment Supporting Section 3 Registration of
Proposed New Uses on Citrus Fruits Group 10-10 and Succulent Beans,
Along with Various Crop Group and Subgroup Conversions'' on pages 35-39
in docket ID number EPA-HQ-OPP-2017-0671.
B. Toxicological Points of Departure/Levels of Concern
Once a pesticide's toxicological profile is determined, EPA
identifies toxicological points of departure (POD) and levels of
concern to use in evaluating the risk posed by human exposure to the
pesticide. For hazards that have a threshold below which there is no
appreciable risk, the toxicological POD is used as the basis for
derivation of reference values for risk assessment. PODs are developed
based on a careful analysis of the doses in each toxicological study to
determine the dose at which no adverse effects are observed (the NOAEL)
and the lowest dose at which adverse effects of concern are identified
(the LOAEL). Uncertainty/safety factors are used in conjunction with
the POD to calculate a safe exposure level--generally referred to as a
population-adjusted dose (PAD) or a reference dose (RfD)--and a safe
margin of exposure (MOE). For non-threshold risks, the Agency assumes
that any amount of exposure will lead to some degree of risk. Thus, the
Agency estimates risk in terms of the probability of an occurrence of
the adverse effect expected in a lifetime. For more information on the
general principles EPA uses in risk characterization and a complete
description of the risk assessment process, see https://www2.epa.gov/pesticide-science-and-assessing-pesticide-risks/assessing-human-health-risk-pesticides.
A summary of the toxicological endpoints for mandipropamid used for
human risk assessment is shown in Table 1 of this unit.
[[Page 10697]]
Table 1--Summary of Toxicological Doses and Endpoints for Mandipropamid for Use in Human Health Risk Assessment
----------------------------------------------------------------------------------------------------------------
Point of departure and
Exposure/scenario uncertainty/safety RfD, PAD, LOC for risk Study and toxicological
factors assessment effects
----------------------------------------------------------------------------------------------------------------
Acute dietary(All populations, No appropriate endpoint for a single exposure was identified in the
including infants and children, and database.
females 13-49).
--------------------------------------------------------------------------
Chronic dietary (All populations).... NOAEL= 5 mg/kg/day..... Chronic RfD = 0.05 mg/ Chronic toxicity study--
UFA = 10x.............. kg/day. dog.
UFH = 10x.............. cPAD = 0.05 mg/kg/day.. LOAEL = 40 mg/kg/day,
FQPA SF = 1x........... based on increased
incidence and severity
of microscopic pigment
in the liver, and
increased alkaline
phosphatase activity
in both sexes, as well
as increased alanine
aminotransferase
activity in males.
--------------------------------------------------------------------------
Cancer (Oral, dermal, inhalation).... Classified as not likely to be carcinogenic to humans.
----------------------------------------------------------------------------------------------------------------
FQPA SF = Food Quality Protection Act Safety Factor. LOAEL = lowest-observed-adverse-effect-level. mg/kg/day =
milligram/kilogram/day. NOAEL = no-observed-adverse-effect-level. PAD = population adjusted dose (a = acute, c
= chronic). RfD = reference dose. UF = uncertainty factor. UFA = extrapolation from animal to human
(interspecies). UFH = potential variation in sensitivity among members of the human population (intraspecies).
C. Exposure Assessment
1. Dietary exposure from food and feed uses. In evaluating dietary
exposure to mandipropamid, EPA considered exposure under the
petitioned-for tolerances as well as all existing mandipropamid
tolerances in 40 CFR 180.637. EPA assessed dietary exposures from
mandipropamid in food as follows:
i. Acute exposure. Quantitative acute dietary exposure and risk
assessments are performed for a food-use pesticide, if a toxicological
study has indicated the possibility of an effect of concern occurring
as a result of a 1-day or single exposure. No such effects were
identified in the toxicological studies for mandipropamid; therefore, a
quantitative acute dietary exposure assessment is unnecessary.
ii. Chronic exposure. In conducting the chronic dietary exposure
assessment, EPA used Dietary Exposure Evaluation Model software with
the Food Commodity Intake Database (DEEM-FCID) Version 3.16, which uses
food consumption data from the U.S.
Department of Agriculture's (USDA's) National Health and Nutrition
Examination Survey, ``What We Eat in America'' (NHANES/WWEIA) from 2003
through 2008. As to residue levels in food, the chronic dietary risk
assessment assumed tolerance-level residues in all commodities with
existing tolerances except tuberous and corm vegetable subgroup 1C. For
the chronic dietary risk assessment, this subgroup was assessed at
0.115 ppm, which assumes tolerance-level residues of parent
mandipropamid (0.09 ppm), and includes metabolite SYN 500003 in parent-
equivalents (at 0.025 ppm). Tolerance-level residues associated with
the proposed new uses and crop group conversions were also used in the
assessment. The Agency's 2018 Default Processing Factors were used for
all processed commodities for which they were available. The empirical
processing factor from the grape processing study was used for grape
wine/sherry (1.5X). A processing factor was not used for grape raisin
because a tolerance is currently established in raisin. Similarly,
processing factors were not used for citrus oil and dried pulp because
the Agency is establishing separate tolerances in these commodities.
iii. Cancer. Based on the lack of evidence of carcinogenicity or
genotoxicity, the Agency has classified mandipropamid as ``not likely
to be a human carcinogen'' and therefore, there is no concern for
cancer risk.
iv. Anticipated residue and percent crop treated (PCT) information.
EPA did not use anticipated residue or PCT information in the dietary
assessment for mandipropamid. Tolerance level residues and 100 PCT were
assumed for all food commodities except as noted in section III.C.ii.
2. Dietary exposure from drinking water. The Agency used screening
level water exposure models in the dietary exposure analysis and risk
assessment for mandipropamid in drinking water. These simulation models
take into account data on the physical, chemical, and fate/transport
characteristics of mandipropamid. Further information regarding EPA
drinking water models used in pesticide exposure assessment can be
found at https://www2.epa.gov/pesticide-science-and-assessing-pesticide-risks/about-water-exposure-models-used-pesticide.
Based on the FQPA Index Reservoir Screening Tool (FIRST) and
Pesticide Root Zone Model Ground Water (PRZM GW), the estimated
drinking water concentrations (EDWCs) of mandipropamid for chronic
exposures are estimated to be 9.0 ppb for surface water and 79 ppb for
ground water.
Modeled estimates of drinking water concentrations were directly
entered into the dietary exposure model. For the chronic dietary risk
assessment, the water concentration value of 79 ppb was used to assess
the contribution to drinking water.
3. From non-dietary exposure. The term ``residential exposure'' is
used in this document to refer to non-occupational, non-dietary
exposure (e.g., for lawn and garden pest control, indoor pest control,
termiticides, and flea and tick control on pets).
Mandipropamid is not registered for any specific use patterns that
would result in residential exposure.
4. Cumulative effects from substances with a common mechanism of
toxicity. Section 408(b)(2)(D)(v) of FFDCA requires that, when
considering whether to establish, modify, or revoke a tolerance, the
Agency consider ``available information'' concerning the cumulative
effects of a particular pesticide's residues and ``other substances
that have a common mechanism of toxicity.''
EPA has not found mandipropamid to share a common mechanism of
toxicity with any other substances, and mandipropamid does not appear
to produce a toxic metabolite produced by other substances. For the
purposes of this tolerance action, therefore, EPA has
[[Page 10698]]
assumed that mandipropamid does not have a common mechanism of toxicity
with other substances. For information regarding EPA's efforts to
determine which chemicals have a common mechanism of toxicity and to
evaluate the cumulative effects of such chemicals, see EPA's website at
https://www2.epa.gov/pesticide-science-and-assessing-pesticide-risks/cumulative-assessment-risk-pesticides.
D. Safety Factor for Infants and Children
1. In general. Section 408(b)(2)(C) of FFDCA provides that EPA
shall apply an additional tenfold (10X) margin of safety for infants
and children in the case of threshold effects to account for prenatal
and postnatal toxicity and the completeness of the database on toxicity
and exposure unless EPA determines based on reliable data that a
different margin of safety will be safe for infants and children. This
additional margin of safety is commonly referred to as the FQPA Safety
Factor (SF). In applying this provision, EPA either retains the default
value of 10X, or uses a different additional safety factor when
reliable data available to EPA support the choice of a different
factor.
2. Prenatal and postnatal sensitivity. No evidence of increased
pre- or postnatal quantitative or qualitative susceptibility was
observed. No fetal or maternal toxicity was observed in developmental
toxicity studies in the rat and rabbit. Decreased pup weights were
observed in the rat two-generation reproduction study in the presence
of decreased parental body weight and food utilization.
3. Conclusion. EPA has determined that reliable data show the
safety of infants and children would be adequately protected if the
FQPA SF were reduced to 1x. That decision is based on the following
findings:
i. The toxicity database for mandipropamid is complete.
ii. There is no indication that mandipropamid is a neurotoxic
chemical and there is no need for a developmental neurotoxicity study
or additional UFs to account for neurotoxicity.
iii. There is no evidence that mandipropamid results in increased
susceptibility in in utero rats or rabbits in the prenatal
developmental studies or in young rats in the 2-generation reproduction
study.
iv. There are no residual uncertainties identified in the exposure
databases. The dietary food exposure assessments were performed based
on 100 PCT and tolerance-level residues except as noted in section
III.C.ii. EPA made conservative (protective) assumptions in the ground
and surface water modeling used to assess exposure to mandipropamid in
drinking water. These assessments will not underestimate the exposure
and risks posed by mandipropamid.
E. Aggregate Risks and Determination of Safety
EPA determines whether acute and chronic dietary pesticide
exposures are safe by comparing aggregate exposure estimates to the
acute PAD (aPAD) and chronic PAD (cPAD). For linear cancer risks, EPA
calculates the lifetime probability of acquiring cancer given the
estimated aggregate exposure. Short-, intermediate-, and chronic-term
risks are evaluated by comparing the estimated aggregate food, water,
and residential exposure to the appropriate PODs to ensure that an
adequate MOE exists.
1. Acute risk. An acute aggregate risk assessment takes into
account acute exposure estimates from dietary consumption of food and
drinking water. No adverse effect resulting from a single oral exposure
was identified and no acute dietary endpoint was selected. Therefore,
mandipropamid is not expected to pose an acute risk.
2. Chronic risk. Using the exposure assumptions described in this
unit for chronic exposure, EPA has concluded that chronic exposure to
mandipropamid from food and water will utilize 49% of the cPAD for
children 1-2 years old, the population group receiving the greatest
exposure. There are no residential uses for mandipropamid.
3. Short- and intermediate-term risk. Short- and intermediate-term
aggregate exposure takes into account short- and intermediate-term
residential exposure plus chronic exposure to food and water
(considered to be a background exposure level). Short- and
intermediate-term adverse effects were identified; however,
mandipropamid is not registered for any use patterns that would result
in either short- or intermediate-term residential exposure. Short- and
intermediate-term risk is assessed based on short- and intermediate-
term residential exposure plus chronic dietary exposure. Because there
is no short- or intermediate-term residential exposure and chronic
dietary exposure has already been assessed under the appropriately
protective cPAD (which is at least as protective as the POD used to
assess short-term risk), no further assessment of short- or
intermediate-term risk is necessary, and EPA relies on the chronic
dietary risk assessment for evaluating short- and intermediate-term
risk for mandipropamid.
4. Aggregate cancer risk for U.S. population. Based on the lack of
evidence of carcinogenicity in two adequate rodent carcinogenicity
studies, mandipropamid is not expected to pose a cancer risk to humans.
5. Determination of safety. Based on these risk assessments, EPA
concludes that there is a reasonable certainty that no harm will result
to the general population, or to infants and children from aggregate
exposure to mandipropamid residues.
IV. Other Considerations
A. Analytical Enforcement Methodology
There is an adequate enforcement method available for the
quantitation of mandipropamid in plant commodities. Method RAM 415/01,
using high performance liquid chromatography with tandem mass
spectrometric detection (LC/MS/MS), has been adequately validated by an
independent laboratory. It has a validated limit of quantitation (LOQ)
of 0.01 ppm. An acceptable confirmatory method is also available.
The method may be requested from: Chief, Analytical Chemistry
Branch, Environmental Science Center, 701 Mapes Rd., Ft. Meade, MD
20755-5350; telephone number: (410) 305-2905; email address:
residuemethods@epa.gov.
B. International Residue Limits
In making its tolerance decisions, EPA seeks to harmonize U.S.
tolerances with international standards whenever possible, consistent
with U.S. food safety standards and agricultural practices. EPA
considers the international maximum residue limits (MRLs) established
by the Codex Alimentarius Commission (Codex), as required by FFDCA
section 408(b)(4). The Codex Alimentarius is a joint United Nations
Food and Agriculture Organization/World Health Organization food
standards program, and it is recognized as an international food safety
standards-setting organization in trade agreements to which the United
States is a party. EPA may establish a tolerance that is different from
a Codex MRL; however, FFDCA section 408(b)(4) requires that EPA explain
the reasons for departing from the Codex level.
There are no harmonization issues with Codex regarding the new use
on citrus fruits because Codex has not established MRLs for
mandipropamid in citrus commodities. Additionally, Codex has not
established an MRL in
[[Page 10699]]
snap beans, so this is not a harmonization issue. Regarding the updated
crop group/subgroup conversions, the tolerance in leafy vegetable group
4-16 is harmonized with the corresponding Codex MRLs. The tolerance in
Brassica head and stem vegetable group 5-16, and the individual
tolerance in kohlrabi, is harmonized with the Codex MRLs in cabbage and
Chinese napa cabbage, but not the Codex MRL in broccoli. There are no
Codex MRLs in Brussels sprouts, cauliflower or kohlrabi. The EPA is not
harmonizing with the Codex MRL in broccoli because it is lower than the
U.S. tolerance in Brassica head and stem vegetable group 5-16; setting
a lower tolerance in broccoli could result in violative residues for
U.S. growers. The tolerance in leaf petiole subgroup 22B, with
individual tolerances in celtuce and Florence fennel, is harmonized
with the Codex MRL in celery.
C. Revisions to Petitioned-For Tolerances
EPA's tolerance levels are expressed to provide sufficient
precision for enforcement purposes, and this may include the addition
of trailing zeros (0.50 ppm rather than the proposed 0.5 ppm). The
Agency does this in order to avoid the situation where rounding of an
observed violative residue to the level of precision of the tolerance
expression would result in a residue being considered non-violative
(such as 0.54 ppm being rounded to 0.5 ppm). EPA made this revision for
Fruit, citrus, group 10-10, Kohlrabi, and Vegetable, Brassica, head and
stem, group 5-16.
Because the petitioner proposed separate tolerances in both
subgroups 4-16A and 4-16B at 25 ppm, the Agency is establishing a
single tolerance in leafy vegetable group 4-16 at 25 ppm rather than
separate tolerances in the two subgroups. In addition, the Agency
revised the commodity terminology to use the correct commodity
definition for Florence fennel, which is Fennel, Florence, fresh leaves
and stalk.
The proposed tolerance in citrus dried pulp (0.14 ppm) was
incorrectly based on the dried pulp processing factor (2.9X) multiplied
by the lowest average field trial value (LAFT) of 0.049 ppm from the
orange field trials. However, per Office of Chemical Safety and
Pollution Prevention (OCSPP) Residue Chemistry Test Guideline 860.1520,
EPA based the tolerance on the processing factor (2.9X) multiplied by
the highest average field trial value (HAFT) of 0.231 ppm from the
lemon field trials (which had the highest HAFT of the three
representative commodities), yielding a result of 0.67 ppm. Per the
rounding protocol in the Organization for Economic Cooperation and
Development (OECD) MRL Calculator User Guide, this result was increased
to 0.70 ppm.
Similarly, the proposed tolerance in citrus oil (2.2 ppm) was
incorrectly based on the oil processing factor (45X) multiplied by the
LAFT of 0.049 ppm from the orange field trials. As for dried pulp, EPA
based the tolerance in citrus oil on the processing factor (45X)
multiplied by the HAFT of 0.231 ppm from the lemon field trials,
yielding a result of 10.4 ppm. Per the rounding protocol in the OECD's
MRL Calculator User Guide this result was increased to 15 ppm.
V. Conclusion
Therefore, tolerances are established for residues of mandipropamid
in or on Asparagus bean, edible podded at 0.90 ppm; Bean (Phaseolus
spp.), edible podded at 0.90 ppm; Bean (Vigna spp.), edible podded at
0.90 ppm; Catjang bean, edible podded at 0.90 ppm; Celtuce at 20 ppm;
Chinese longbean, edible podded at 0.90 ppm; Citrus, dried pulp at 0.70
ppm; Citrus, oil at 15 ppm; Cowpea, edible podded at 0.90 ppm; Fennel,
Florence, fresh leaves and stalk at 20 ppm; French bean, edible podded
at 0.90 ppm; Fruit, citrus, group 10-10 at 0.50 ppm; Garden bean,
edible podded at 0.90 ppm; Goa bean, edible podded at 0.90 ppm; Green
bean, edible podded at 0.90 ppm; Guar bean, edible podded at 0.90 ppm;
Jackbean, edible podded at 0.90 ppm; Kidney bean, edible podded at 0.90
ppm; Kohlrabi at 3.0 ppm; Lablab bean, edible podded at 0.90 ppm; Leaf
petiole vegetable subgroup 22B at 20 ppm; Moth bean, edible podded at
0.90 ppm; Mung bean, edible podded at 0.90 ppm; Navy bean, edible
podded at 0.90 ppm; Rice bean, edible podded at 0.90 ppm; Scarlet
runner bean, edible podded at 0.90 ppm; Snap bean, edible podded at
0.90 ppm; Sword bean, edible podded at 0.90 ppm; Urd bean, edible
podded at 0.90 ppm; Vegetable, Brassica, head and stem, group 5-16 at
3.0 ppm; Vegetable, leafy, group 4-16 at 25 ppm; Vegetable soybean,
edible podded at 0.90 ppm; Velvet bean, edible podded at 0.90 ppm; Wax
bean, edible podded at 0.90 ppm; Winged pea, edible podded at 0.90 ppm;
and Yardlong bean, edible podded at 0.90 ppm.
Additionally, the existing tolerances in/on Bean, snap at 0.90 ppm;
Brassica, head and stem, subgroup 5A at 3 ppm; Brassica, leafy greens,
subgroup 5B at 25 ppm; and Vegetable, leafy except Brassica, group 4 at
20 ppm are removed as unnecessary since they are covered by the new
tolerances.
VI. Statutory and Executive Order Reviews
This action establishes tolerances under FFDCA section 408(d) in
response to a petition submitted to the Agency. The Office of
Management and Budget (OMB) has exempted these types of actions from
review under Executive Order 12866, entitled ``Regulatory Planning and
Review'' (58 FR 51735, October 4, 1993). Because this action has been
exempted from review under Executive Order 12866, this action is not
subject to Executive Order 13211, entitled ``Actions Concerning
Regulations That Significantly Affect Energy Supply, Distribution, or
Use'' (66 FR 28355, May 22, 2001) or Executive Order 13045, entitled
``Protection of Children from Environmental Health Risks and Safety
Risks'' (62 FR 19885, April 23, 1997), nor is it considered a
regulatory action under Executive Order 13771, entitled ``Reducing
Regulations and Controlling Regulatory Costs'' (82 FR 9339, February 3,
2017). This action does not contain any information collections subject
to OMB approval under the Paperwork Reduction Act (PRA) (44 U.S.C. 3501
et seq.), nor does it require any special considerations under
Executive Order 12898, entitled ``Federal Actions to Address
Environmental Justice in Minority Populations and Low-Income
Populations'' (59 FR 7629, February 16, 1994).
Since tolerances and exemptions that are established on the basis
of a petition under FFDCA section 408(d), such as the tolerances in
this final rule, do not require the issuance of a proposed rule, the
requirements of the Regulatory Flexibility Act (RFA) (5 U.S.C. 601 et
seq.), do not apply.
This action directly regulates growers, food processors, food
handlers, and food retailers, not States or tribes, nor does this
action alter the relationships or distribution of power and
responsibilities established by Congress in the preemption provisions
of FFDCA section 408(n)(4). As such, the Agency has determined that
this action will not have a substantial direct effect on States or
tribal governments, on the relationship between the national government
and the States or tribal governments, or on the distribution of power
and responsibilities among the various levels of government or between
the Federal Government and Indian tribes. Thus, the Agency has
determined that Executive Order 13132, entitled ``Federalism'' (64 FR
43255, August 10, 1999) and Executive Order 13175,
[[Page 10700]]
entitled ``Consultation and Coordination with Indian Tribal
Governments'' (65 FR 67249, November 9, 2000) do not apply to this
action. In addition, this action does not impose any enforceable duty
or contain any unfunded mandate as described under Title II of the
Unfunded Mandates Reform Act (UMRA) (2 U.S.C. 1501 et seq.).
This action does not involve any technical standards that would
require Agency consideration of voluntary consensus standards pursuant
to section 12(d) of the National Technology Transfer and Advancement
Act (NTTAA) (15 U.S.C. 272 note).
VII. Congressional Review Act
Pursuant to the Congressional Review Act (5 U.S.C. 801 et seq.),
EPA will submit a report containing this rule and other required
information to the U.S. Senate, the U.S. House of Representatives, and
the Comptroller General of the United States prior to publication of
the rule in the Federal Register. This action is not a ``major rule''
as defined by 5 U.S.C. 804(2).
List of Subjects in 40 CFR Part 180
Environmental protection, Administrative practice and procedure,
Agricultural commodities, Pesticides and pests, Reporting and
recordkeeping requirements.
Dated: March 14, 2019.
Michael Goodis,
Director, Registration Division, Office of Pesticide Programs.
Therefore, 40 CFR chapter I is amended as follows:
PART 180--[AMENDED]
0
1. The authority citation for part 180 continues to read as follows:
Authority: 21 U.S.C. 321(q), 346a and 371.
0
2. In Sec. 180.637, in the table to paragraph (a):
0
a. Add alphabetically the entry ``Asparagus bean, edible podded'';
0
b. Remove the entry for ``Bean, snap'';
0
c. Add alphabetically the entries ``Bean (Phaseolus spp.), edible
podded'' and ``Bean (Vigna spp.), edible podded'';
0
d. Remove the entries for ``Brassica, head and stem, subgroup 5A'' and
``Brassica, leafy greens, subgroup 5B''; and
0
e. Add alphabetically the entries ``Catjang bean, edible podded'';
``Celtuce''; ``Chinese longbean, edible podded''; ``Citrus, dried
pulp''; ``Citrus, oil''; ``Cowpea, edible podded''; ``Fennel, Florence,
fresh leaves and stalk''; ``French bean, edible podded''; ``Fruit,
citrus, group 10-10''; ``Garden bean, edible podded''; ``Goa bean,
edible podded''; ``Green bean, edible podded''; ``Guar bean, edible
podded''; ``Jackbean, edible podded''; ``Kidney bean, edible podded'';
``Kohlrabi''; ``Lablab bean, edible podded''; ``Leaf petiole vegetable
subgroup 22B''; ``Moth bean, edible podded''; ``Mung bean, edible
podded''; ``Navy bean, edible podded''; ``Rice bean, edible podded'';
``Scarlet runner bean, edible podded''; ``Snap bean, edible podded'';
``Sword bean, edible podded''; ``Urd bean, edible podded'';
``Vegetable, Brassica, head and stem, group 5-16''; and ``Vegetable,
leafy, group 4-16'';
0
f. Remove the entry for ``Vegetable, leafy except Brassica, group 4'';
and
0
g. Add alphabetically the entries ``Vegetable soybean, edible podded'';
``Velvet bean, edible podded''; ``Wax bean, edible podded''; ``Winged
pea, edible podded''; and ``Yardlong bean, edible podded''.
The additions read as follows:
Sec. 180.637 Mandipropamid; tolerances for residues.
(a) * * *
------------------------------------------------------------------------
Parts per
Commodity million
------------------------------------------------------------------------
Asparagus bean, edible podded............................... 0.90
* * * * *
Bean (Phaseolus spp.), edible podded........................ 0.90
Bean (Vigna spp.), edible podded............................ 0.90
Catjang bean, edible podded................................. 0.90
Celtuce..................................................... 20
Chinese longbean, edible podded............................. 0.90
Citrus, dried pulp.......................................... 0.70
Citrus, oil................................................. 15
Cowpea, edible podded....................................... 0.90
Fennel, Florence, fresh leaves and stalk.................... 20
French bean, edible podded.................................. 0.90
Fruit, citrus, group 10-10.................................. 0.50
* * * * *
Garden bean, edible podded.................................. 0.90
* * * * *
Goa bean, edible podded..................................... 0.90
* * * * *
Green bean, edible podded................................... 0.90
Guar bean, edible podded.................................... 0.90
* * * * *
Jackbean, edible podded..................................... 0.90
Kidney bean, edible podded.................................. 0.90
Kohlrabi.................................................... 3.0
Lablab bean, edible podded.................................. 0.90
Leaf petiole vegetable subgroup 22B......................... 20
Moth bean, edible podded.................................... 0.90
Mung bean, edible podded.................................... 0.90
Navy bean, edible podded.................................... 0.90
* * * * *
Rice bean, edible podded.................................... 0.90
Scarlet runner bean, edible podded.......................... 0.90
Snap bean, edible podded.................................... 0.90
Sword bean, edible podded................................... 0.90
Urd bean, edible podded..................................... 0.90
Vegetable, Brassica, head and stem, group 5-16.............. 3.0
* * * * *
Vegetable, leafy, group 4-16................................ 25
Vegetable soybean, edible podded............................ 0.90
* * * * *
Velvet bean, edible podded.................................. 0.90
Wax bean, edible podded..................................... 0.90
Winged pea, edible podded................................... 0.90
Yardlong bean, edible podded................................ 0.90
------------------------------------------------------------------------
* * * * *
[FR Doc. 2019-05406 Filed 3-21-19; 8:45 am]
BILLING CODE 6560-50-P